Look into AbbVie's strategy a company built around its blockbuster Humira, now diversifying its pipeline after the patent ...
Basket Trials Evaluating Tazemetostat Combinations for Multiple New Heme and Solid Tumor Cancers to be Initiated in Second Half 2021 “The recent accelerated approvals of TAZVERIK in Epithelioid ...
Multiple clinical data readouts expected in 2026 present opportunity for substantial value creationKOASTAL-2 and -3 on track for consolidated ...
Welcome to the Regeneron conference call to discuss its Lynozyfic development program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...
AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform ...